CD93 Correlates With Immune Infiltration and Impacts Patient Immunotherapy Efficacy: A Pan-Cancer Analysis

Background: The clinical implementation of immune-checkpoint inhibitors (ICIs) targeting CTLA4, PD-1, and PD-L1 has revolutionized the treatment of cancer. However, the majority of patients do not derive clinical benefit. Further development is needed to optimize the approach of ICI therapy. Immunot...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Zerui, Zheng, Mengli, Ding, Qiang, Liu, Mei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cell and Developmental Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8886047/
https://www.ncbi.nlm.nih.gov/pubmed/35242761
http://dx.doi.org/10.3389/fcell.2022.817965

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8886047/
https://www.ncbi.nlm.nih.gov/pubmed/35242761
http://dx.doi.org/10.3389/fcell.2022.817965

Ejemplares similares